Gasparrini S.; Cimadamore A.; Scarpelli M.; Massari F.; Doria A.; Mazzucchelli R.; Cheng L.; Lopez-Beltran A.; Montironi R., Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians, «ASIAN JOURNAL OF ANDROLOGY», 2019, 21, pp. 19 - 23 [Scientific article]Open Access
Cimadamore A.; Gasparrini S.; Massari F.; Santoni M.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Montironi R., Emerging molecular technologies in renal cell carcinoma: Liquid biopsy, «CANCERS», 2019, 11, Article number: 196 , pp. 1 - 9 [Scientific article]Open Access
Prisciandaro M.; Ratta R.; Massari F., Erratum: Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program (American Journal of Clinical Oncology: Cancer Clinical Trials (2019) 42 (42-45) DOI: 10.1097/COC.0000000000000478), «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2019, 42, pp. 412 - 412 [Scientific article]
Cimadamore A.; Scarpelli M.; Santoni M.; Massari F.; Tartari F.; Cerqueti R.; Lopez-Beltran A.; Cheng L.; Montironi R., Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy, «CURRENT DRUG METABOLISM», 2019, 20, pp. 305 - 312 [Scientific article]
Di Nunno, V.; Frega, G.; Gatto, L.; Brandi, G.; Massari, F., Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: An unassessed issue, «FUTURE ONCOLOGY», 2019, 15, pp. 563 - 565 [Scientific article]
Di Nunno, Vincenzo; Frega, Giorgio; Gatto, Lidia; Brandi, Giovanni; Massari, Francesco, Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue, «FUTURE ONCOLOGY», 2019, 15, pp. 563 - 565 [Scientific article]
Massari F.; Nunno V.D.; Mollica V.; Montironi R.; Cheng L.; Cimadamore A.; Blanca A.; Lopez-Beltran A., Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice, «IMMUNOTHERAPY», 2019, 11, pp. 1507 - 1521 [Scientific article]
Santoni M.; Cimadamore A.; Massari F.; Piva F.; Aurilio G.; Martignetti A.; Scarpelli M.; Di Nunno V.; Gatto L.; Battelli N.; Cheng L.; Lopez-Beltran A.; Montironi R., Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers, «CANCERS», 2019, 11, Article number: 1225 , pp. 1 - 16 [Scientific article]Open Access
Cimadamore, Alessia; Santoni, Matteo; Massari, Francesco; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo, Liquid biopsies in renal cell carcinoma with focus on epigenome analysis, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, Article number: S194 , pp. 1 - 4 [Scientific article]Open Access
Cimadamore A.; Santoni M.; Massari F.; Gasparrini S.; Cheng L.; Lopez-Beltran A.; Montironi R.; Scarpelli M., Microbiome and cancers, with focus on genitourinary tumors, «FRONTIERS IN ONCOLOGY», 2019, 9, Article number: 178 , pp. 1 - 6 [Scientific article]Open Access
Mollica V.; Di Nunno V.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Santoni M.; Scarpelli M.; Montironi R.; Massari F., Molecular mechanisms related to hormone inhibition resistance in prostate cancer, «CELLS», 2019, 8, Article number: 43 , pp. 1 - 15 [Scientific article]Open Access
Di Nunno V.; Santoni M.; Massari F., New Hormonal Agents in Patients with Nonmetastatic Castration-resistant Prostate Cancer: Can We Be Satisfied with an Advantage in Metastasis-free Survival?, «EUROPEAN UROLOGY ONCOLOGY», 2019, 2, pp. 471 - 471 [Scientific article]
Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F, New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes., «CLINICAL GENITOURINARY CANCER», 2019, 1, pp. E871 - E877 [Scientific article]
Di Nunno, Vincenzo; Mollica, Veronica; Santoni, Matteo; Gatto, Lidia; Schiavina, Riccardo; Fiorentino, Michelangelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco, New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes, «CLINICAL GENITOURINARY CANCER», 2019, 17, pp. 871 - 877 [Scientific article]
Di Nunno V.; Mollica V.; Massari F., N-Myc a key gene promoting a worst prostate cancer progression, «TRANSLATIONAL CANCER RESEARCH», 2019, 8, pp. 15 - 17 [Scientific article]
